(19)
(11) EP 1 098 969 A2

(12)

(88) Date of publication A3:
27.04.2000

(43) Date of publication:
16.05.2001 Bulletin 2001/20

(21) Application number: 99938756.6

(22) Date of filing: 15.07.1999
(51) International Patent Classification (IPC)7: C12N 15/11, A61K 31/70, C07H 21/00
(86) International application number:
PCT/US9916/253
(87) International publication number:
WO 0004/141 (27.01.2000 Gazette 2000/04)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 20.07.1998 US 93489 P
26.10.1998 US 179516

(71) Applicants:
  • RIBOZYME PHARMACEUTICALS, INC.
    Boulder, CO 80301 (US)
  • ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc.
    Bloomington, IN 47404 (US)

(72) Inventors:
  • KAO, Cheng, C.
    Bloomington, IN 47401 (US)
  • SIEGEL, Robert, W.
    Jemez Springs, NM 87025 (US)
  • BELLON, Laurent
    Boulder, CO 80301 (US)
  • BEIGELMAN, Leonid
    Longmont, CO 80303 (US)

(74) Representative: Viering, Jentschura & Partner 
Steinsdorfstrasse 6
80538 München
80538 München (DE)

   


(54) USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS